Cellebrite DI (CLBT)
US Market

Cellebrite DI (CLBT) Financial Statements


Cellebrite DI Financial Overview

Cellebrite DI's market cap is currently ―. The company's EPS TTM is $-0.578; its P/E ratio is -21.73; Cellebrite DI is scheduled to report earnings on August 15, 2024, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue--$ 71.67M$ 62.57M$ 62.38M
Gross Profit--$ 57.14M$ 49.48M$ 51.40M
EBIT--$ -1.08M$ -5.60M$ -1.95M
EBITDA--$ 1.22M$ -3.34M$ 166.00K
Net Income Common Stockholders--$ 25.09M$ 33.20M$ 55.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 302.92M$ 183.62M$ 146.54M$ 142.51M$ 165.93M
Total Assets$ 532.88M$ 403.29M$ 352.49M$ 324.84M$ 324.63M
Total Debt$ 59.95M$ 15.36M$ 0.00$ 0.00$ 0.00
Net Debt$ -242.97M$ -168.27M$ -146.54M$ -142.51M$ -165.93M
Total Liabilities$ 498.67M$ 329.43M$ 293.03M$ 300.78M$ 336.85M
Stockholders Equity$ 34.21M$ 73.86M$ 59.46M$ 24.06M$ -12.22M
Cash Flow-
Free Cash Flow--$ -2.59M$ -5.64M$ -12.84M
Operating Cash Flow--$ -556.00K$ -4.07M$ -10.54M
Investing Cash Flow--$ -11.80M$ -31.10M$ -13.40M
Financing Cash Flow--$ 7.30M$ 1.06M$ 3.63M
Currency in USD

Cellebrite DI Earnings and Revenue History

Cellebrite DI Debt to Assets

Cellebrite DI Cash Flow

Cellebrite DI Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis